LBC Credit Partners Provides Second Lien Term Loan to BioMatrix Specialty Pharmacy, LLC to Support the Acquisition of Elwyn Pharmacy Group, LLC

Oct 10, 2017
Deal announcements

Philadelphia, PA, October 10, 2017-LBC Credit Partners ("LBC"), a leading provider of financing solutions to middle market companies, provided a $25.0 million second lien term loan to BioMatrix Specialty Pharmacy, LLC ("BioMatrix" or the "Company") to support the acquisition of Elwyn Pharmacy Group. BioMatrix is a portfolio company of ACON Investments, LLC ("ACON").

LBC served as Administrative Agent and Sole Lender for the second lien term loan.

Headquartered in Weston, Florida, BioMatrix was formed in 2015 through the merger of Matrix Health Group and BiologicTx, two specialty pharmacy companies with a common emphasis on a high-touch, clinically sophisticated and patient-centric care management model. With a network of seven pharmacies, the Company is a leading provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix has relationships with leading physicians, medical facilities and payors; and its Digital Health platform, provides innovative solutions for care givers, patients, payors and other stakeholders.

Elwyn Pharmacy Group is a large multi-location independently owned and operated specialty pharmacy headquartered in Garnet Valley, Pennsylvania. They have additional locations located in Media, Pennsylvania; Glen Rock, New Jersey; as well as Charleston, West Virginia. They are URAC, ACHC and PCAB accredited. 

ACON Investments, LLC is a Washington, DC-based international private equity investment firm that manages private equity funds and special purpose partnerships that make investments in the United States and Latin America. Founded in 1996, ACON has responsibility for managing approximately $5.5 billion of capital. ACON has professionals in Washington, DC, Los Angeles, Mexico City, Sao Paulo and Bogota. 

About LBC Credit Partners

LBC Credit Partners is a leading provider of middle market financing solutions including senior term, unitranche, second lien, junior secured and mezzanine debt and equity co-investments supporting sponsored and non-sponsored transactions. With over $2.9* billion of capital commitments, LBC has made investments in companies located throughout North America across a wide range of industries and is committed to a long-term approach to debt investing. LBC is headquartered in Philadelphia, with offices in Chicago, New York and Los Angeles. To learn more, visit

*Information as of September 2017